Please select the option that best describes you:

How do you approach a patient with Stage I node negative ER+ invasive ductal carcinoma s/p lumpectomy who has an intermediate Oncotype?   

While we await the results of TailorX, what has been the experience in your practice? If the decision for adjuvant chemotherapy is made, do you feel comfortable using AC Q3weeks instead of dose dense? 



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more